Del. Justices Seek Details In $13B Salix Merger Appeal
Shareholder attempts to rescue a challenge to the $13.1 billion Salix Pharmaceuticals Inc. merger with Valeant Pharmaceuticals International Inc. in 2015 hit turbulence in Delaware's Supreme Court on Wednesday, with the...To view the full article, register now.
Already a subscriber? Click here to view full article